Exploring the Controversy: Does NAD+ Supplementation Induce Cancer Risk? cover art

Exploring the Controversy: Does NAD+ Supplementation Induce Cancer Risk?

Exploring the Controversy: Does NAD+ Supplementation Induce Cancer Risk?

Listen for free

View show details

About this listen

  • The Peptique is LIVE! Go to https://thepeptique.com/ to get all your research peptides .As a loyal listener use the discount code POD15 to get 15% off the entire line of products.
  • Have questions? Feel free to reach out to me: tarawest@westwellnessatx.com
  • Want to get started the right way, but don't know where to start. Email me tarawest@westwellnessatx.com to set up a 30 minute $100 session to get your personalized protocol. A special discount on your first order will be included. These spots fill up fast so schedule today!
  • Want the free peptide guide? Email me tarawest@westwellnessatx.com and comment Guide and I'll shoot it right over!
  • Follow me on instagram @westwellnessatx


Takeaways:

  • This podcast episode marks the 50th installment, showcasing significant growth and listener engagement.
  • The primary focus of today's discussion centers on the relationship between NAD and cancer risk.
  • NAD is crucial for cellular functions including energy production, DNA repair, and immune response.
  • Current research presents mixed results regarding NAD's role in cancer, demanding further investigation and caution.
  • NAD supplementation may not inherently cause cancer but could influence existing cancer cell behavior.
  • Listeners are encouraged to conduct their own research and consider their personal health situations regarding NAD usage.


Research Links

NAD+ biology, aging, immunity, DNA repair

  • Covarrubias et al. “NAD+ metabolism and its roles in cellular processes during ageing” (review). https://pmc.ncbi.nlm.nih.gov/articles/PMC7963035/ PMC
  • Ghanem et al. “Inhibitors of NAD+ Production in Cancer Treatment” (NAMPT/NAPRT review). https://pmc.ncbi.nlm.nih.gov/articles/PMC10889166/ PMC
  • Manickam et al. “Nampt: a new therapeutic target for modulating NAD metabolism in cancer and inflammation” (2025 review). https://cdnsciencepub.com/doi/10.1139/cjpp-2024-0400 Canadian Science Publishing

Extracellular metabolism and cellular uptake (do IVs reach cells?)

  • Gasparrini et al. “Enzymology of extracellular NAD metabolism” (ectoenzymes; NR/NMN/NAM import). https://pmc.ncbi.nlm.nih.gov/articles/PMC8038981/ PMC
  • Yusri et al. “The role of NAD+ metabolism and its modulation” (2025 review; NR via ENTs; NMN dephosphorylation; SLC12A8 debate). https://www.nature.com/articles/s44324-025-00067-0 Nature
  • Yaku et al. “NR and NMN: similarities and differences” (2025 perspective; NMN→NR conversion before uptake). https://www.science.org/doi/10.1126/sciadv.adr1538 Science

Human IV NAD+ / IV NR data

  • Grant et al. “A Pilot Study… during a 6-hour intravenous infusion of NAD+” (750 mg IV NAD+, plasma/urine...
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.